Development Office Funding Opportunities

Eligibility:

Applicant must be an ACR or ARP member at the time of submission and for the duration of the award
•ACR Members:
oHave earned a DO or MD degree and who have completed a Rheumatology fellowship.
oIndividuals more than 7 years from the beginning of fellowship (or 8 years for pediatric rheumatologists) at the time of award start date may not apply
•ARP Members:
oHave earned a PhD*, DSc, or equivalent doctoral degree.
oMust be within 5 years of terminal degree at the time of award start date.

About: 
This award is intended to support early-stage investigators with a faculty appointment during the period that they are developing a project that will be competitive for NIH and/or equivalent funding. It is not intended to be a second postdoctoral fellowship. The purpose is to provide support for basic science, translational, and clinical investigators engaged in research relevant to the rheumatic diseases for the period between the completion of post-doctorate fellowship training and establishment as an independent investigator.

Highlighted Topic: Adult Dermatomyositis
Investigators pursuing novel research ideas addressing the disease area of adult dermatomyositis are encouraged to apply for funding via the Norman Family Fund for Dermatomyositis Research.

Eligibility:

Applicant must be an ACR or ARP member at the time of submission and for the duration of the award
•ACR Members:
oHave earned a DO or MD degree and by the start of the award term have completed at least 1 year of training in an ACGME accredited rheumatology training program.
oIndividuals more than 4 years from the beginning of fellowship (or 5 years for pediatric rheumatologists) at the time of award start date may not apply
•ARP Members:
oHave earned a PhD*, DSc, or equivalent doctoral degree by the time of award start.
oMust be within 3 years of terminal degree at the time of award start date.

About:
This award is designed for individuals in the early stages of their career, typically Fellows, including those without significant research experience who plan to embark on careers in rheumatic disease research.
The purpose of this award is to provide a structured research training program for rheumatologists or health professionals in the field of rheumatology.

Highlighted Topic: Adult Dermatomyositis
Investigators pursuing novel research ideas addressing the disease area of adult dermatomyositis are encouraged to apply for funding via the Norman Family Fund for Dermatomyositis Research.

Highlighted Topic: Spondyloarthritis Research: Through a generous contribution by UCB, funding for one Scientist Development Award (SDA) has been provided for research focused on advancing the understanding and treatment of spondyloarthritis. Early career investigators who conduct research on spondyloarthritis, and meet all eligibility criteria, are encouraged to apply this cycle through the SDA mechanism. Please note, only applicants who were recommended for funding by the study section will be considered for this support, and UCB does not have any role or information regarding the scientific peer review process conducted by the Foundation.

About: We support research that advances the scientific understanding of fundamental characteristics or behaviors of living or synthetic systems. We are especially interested in emergent properties that cannot be fully explained by the known characteristics of a complex system’s individual parts (e.g., an organism’s individual genes or cells).
In 2026, the emergent properties prioritized by Life Sciences are agency, consciousness, and intelligence, with particular interest in poorly understood emergent phenomena such as non-neural forms of intelligence and agency, and the physical, biological, and computational processes that underlie consciousness.
In 2026, we are prioritizing foundational research with a focus on mechanistically understanding the genetics behind protein activity. We are particularly interested in research that connects genome regulation and RNA-regulatory mechanisms to their downstream effects on protein activity. In turn, our interests extend to how these effects impact cellular and organismal characteristics that contribute to human health and disease (including disease risk and resistance). Understanding the interplay between these layers of regulation will create powerful opportunities to translate fundamental discoveries into practical applications that enhance human health.

Deadline: July 30, 2026

Eligibility:

•This application is open to global academic institutions, for-profit organizations, and other entities. Any individual(s) with the skills, knowledge, and internal or external resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to submit an application through their institution.”

About: This RFA seeks applications at the intersection of PROTACs and male contraception in three strategic areas:

•Development of PROTACs acting against specific male contraceptive targets Example projects may include:

•Demonstration of target-specific degradation in relevant cell types and/or sperm
Evidence of functional impact on fertility-relevant phenotypes
In vivo or in vitro proof-of-concept data supporting contraceptive potential

•Characterization of testis- or sperm-enriched Ubiquitin E3 ligases Example projects may include:
Cell type-specific expression profiling and localization studies – Assessment of function and essentiality for male reproduction
Assessment of feasibility as recruiting partners for degraders

•Discovery and validation of new E3 recruiting elements (E3REs) Example projects may include:
Development of tool compounds or assays to screen for E3 ligase engagement
Screening or development of novel molecules that may act as E3REs for E3 Ligases specific to the male reproductive tract.
Characterization of binding, selectivity, and cell permeability of potential E3REs.

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period.

•Be an early career researcher, defined as completing initial residency training within eight (8) years of the start of the award period for physician applicants; non-physician applicants must be within 8 years of terminal research degree (PhD or equivalent). 

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period. Emergency medicine residents in their final year of residency may apply, subject to the same stipulation of holding a university appointment at the start of the award period.

•Not have received a similar grant for the same purpose as the SAEMF proposal (no overlapping funds)  

About: The Emerging Infectious Disease and Preparedness Grant provides up to $100,000 over a one-year period starting July 1 to support emergency care research related to emerging infectious disease, such as influenza, COVID-19, and other bacterial or viral infections. This award is not limited to specific conditions and may study an infectious disease at any point in its epidemiologic trajectory. This award seeks to support an ambitious program of acute care science in emerging infectious disease that may include:

•Diagnostics
•Patient and provider safety
•Intervention/therapeutics
•Disaster preparedness
•Other relevant topic areas

In addition to existing basic, translational, and clinical research methods, projects leveraging innovative methodological designs, such as implementation trials, computational methods and data science are encouraged. While the focus is on self-limited research projects that are impactful in the current or future practice of emergency medicine and can be completed in a one-year time frame, the funds apportioned for this award are provided with the hope for investigators to propose an ambitious program of research that can lead to a sustained program of externally supported funded research.

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period.

•Not have previously received a SAEMF Large Project Grant.

•Not have received an NIH R01 award or equivalent.

About:  The SAEMF Research Large Project Grant awards $150,000 over a two-year period ($75,000 per year) to support an emergency medicine faculty member to conduct a large-scale research project to advance his/her career and subsequently obtain federal funding by developing pilot data.

•The goals of the Research Large Project Grant are to:

•Answer important scientific questions in emergency medicine.

•Foster the growth of the awardee.

•Help the awardee become an independently funded scientist in emergency medicine research.

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period.

About:  The goals of the SAEMF Research Training Grant are to:

•Provide support to an emergency medicine academician awardee for two years of concentrated training and mentorship with an emphasis on learning research methodology. The award is intended to support the development of sound research skills rather than a specific research project.

•Enhance the likelihood of the selection of an academic research career by the awardee.

•Facilitate the support of research training in the awardee’s host institution for emergency medicine research scientists.

•Encourage the awardee’s academic development and involvement in emergency medicine research.

Eligibility:

•Be a member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, PharmD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of the award period, or be an emergency medicine resident in good standing in an Accreditation Council on Graduate Medical Education (ACGME)-approved emergency medicine residency program at the start of the award period. The applicant may work as a clinician at an institution other than the host institution or the institution at which the project will be conducted.

•Not have previously received the SAEMF/ED Benchmarking Alliance Clinical Operations Research Grant and not have received an NIH R01 award or equivalent.

About: The SAEMF/ED Benchmarking Alliance Clinical Operations Research Grant awards $50,000 over a two year period ($25,000 per year) to support an emergency medicine faculty member or trainee to conduct a research project to promote research on ED clinical operations. Operations research projects will investigate the experience of patients during their ED stay. This most often relates to flow and how factors such as consult turnaround time, lab / imaging turnaround time and other processes effect the patient. Patient satisfaction and ED design are also relevant. Special consideration will be given to projects addressing hospital over-capacity and resultant boarding of inpatients in the ED. Individuals with an interest in an administrative leadership or a research career relating to ED operations and care delivery are strongly encouraged to apply.

Eligibility:

Applicant must be an ACR or ARP member at the time of submission and for the duration of the award
•ACR Members:
oApplicant must be an NIH K08, K23, K25, VA CDA, or equivalent 4- or 5-year award recipient. The applicant must be in years 2, 3 or 4 of their award at the time of application.
oHave earned a DO, MD, MD/PhD, or DO/PhD degree or be currently enrolled in an ACGME accredited clinical training program.
•ARP Members:
oApplicant must be an NIH K01, K08, K23, K25, VA CDA, or equivalent 4- or 5-year award recipient. The applicant must be in years 2, 3 or 4 of their award at the time of application.
oHave earned a PhD*, DSc, or equivalent doctoral degree.

About:
The NIH K Series and VA CDA awards provide limited resources to cover research costs, such as essential laboratory supplies or support staff (e.g., salary support for a research technician, research assistant/coordinator, or statistician), which are crucial to the successful transition of junior investigators to independent investigators. This award is designed to address the needs of these investigators and serve as a supplement to the NIH individual K series, VA CDA, or equivalent 4- or 5-year award mechanism.
Applicants should propose a new project or expansion of their career development award that demonstrates growth of the aims of the initial award and an independent direction for the investigator leading to the submission of an R award or equivalent.

Eligibility:

•Eligible applicants include PhD candidates (preliminary exams completed) and medical professional students (to support a one-year hiatus from professional training to pursue research), and post-doctoral fellows (within 3 years of PhD or clinical degree).

oMedical professional training programs and clinical degrees include the following training programs and degrees: DDS, DO, DVM, MD, VMD and equivalents.

•Fellow applicants must have a principal mentor who satisfies the institutional requirements of a PI as defined above under the Research Tier I and II Grants heading.

About: The Fellow-Initiated application will, in most cases, address a Tier II level question. In rare cases the research may approach Tier I level research in scope. Research interests include:

•Discrete studies or deliverables involving drug repurposing, models, etc.
•Research needs designed to make possible a significant and new research grant
•Research needs designed to improve a significant research grant resubmission
•Analysis of previously compiled data or research resources
•Pre-clinical extension to an alternate syndrome of a previously validated therapy

Amount: $100,000 over 1-2 years

• Opportunity for competitive renewal

Eligibility: —

Amount: $50,000 over 1-2 years

• Opportunity for competitive renewal

Eligibility: —

About: Research interests include:

• Discrete studies or deliverables involving drug repurposing, models, etc.

• Research needs designed to make possible a significant and new research grant

• Research needs designed to improve a significant research grant resubmission

• Analysis of previously compiled data or research resources

• Pre-clinical extension to an alternate syndrome of a previously validated therapy  

Eligibility:

•Anesthesiology faculty members of any rank (junior or senior faculty)
About: Research in Education Grants (REG) advance the careers and knowledge of anesthesiologists interested in improving the concepts, methods and techniques of education in anesthesiology.

Eligibility:

•Anesthesiology faculty members of any rank (junior or senior faculty)

Eligibility:

•Anesthesiology trainees after CA-1 year 

Eligibility:

•Applicants must be established as an independent investigator in the field of gastric biology.

oMD applicants are considered “established” if 7 or more years have elapsed following the completion of clinical training
oPhD applicants are considered “established” if 7 or more years have elapsed following the awarding of the PhD degree

•Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO).

•Applicants performing any type of research (basic, translational, clinical) relevant to gastric cancer are eligible to apply.

Eligibility: —

About:The mission of Weiss Asset Management Foundation is to reduce human suffering globally. With an Allocation Committee composed of development economists and practitioners, we support evidence-based, cost-effective programs and research that we believe will yield a high, risk-adjusted social return on investment.
Examples of prior grants include support for evidence-based nutrition programming for children suffering from severe acute malnutrition, policy-oriented research to reduce barriers to vaccination programs, and technical assistance for government water-purification efforts.
We welcome all proposals related to our goal of reducing human suffering globally. We expect most grants to fall into the following two categories:

Project-based Support: We support work for specific initiatives.

•Research with high potential for impact on policy or programs
•Technical assistance
•Operational innovations and experiments for unique programmatic opportunities; and
•Support for proven, cost-effective programs that face funding gaps
•Note: For research proposals, we prioritize rigorous causal identification, data science for targeting, and important monitoring or descriptive work that could lead to action. We deprioritize simple correlations or purely qualitative work.

•General Support: We also provide general support for highly cost-effective organizations or programs.

Eligibility:

•Primary investigators (not co-investigators) who have completed work on a FAER Mentored Research Training Grant within the past two years and are in the process of revising and resubmitting an application for new independent research funding (R01/21, VA Merit, AHRQ or equivalent). The application for new independent funding should have received a priority score or percentile but have fallen just outside of the funding threshold